He-He-Shu-Yang formula alleviates liver fibrosis by inhibiting hepatic stellate cell activation <i>in vivo</i> and <i>in vitro</i>
HHSY effectively treats liver fibrosis, likely by inhibiting HSC activation through the NOX4/ROS/NLRP3 pathway. This underscores HHSY's clinical relevance as a potential therapeutic option for liver fibrosis.
Authors
- Yousheng Mo (ORCID: https://orcid.org/0000-0001-7599-6015)
- Xiaoling Chi (ORCID: https://orcid.org/0000-0003-3193-1943)
- Huanming Xiao (ORCID: https://orcid.org/0000-0002-8739-0720)
- Mei-Jie Shi
- Fo-Lai Zeng
- Yu-Bao Xie
Institutions
- Guangzhou University of Chinese Medicine (CN)
- Key Laboratory of Guangdong Province (CN)
- Guangdong Provincial Hospital of Traditional Chinese Medicine (CN)
Publication Details
- Journal
- World Journal of Hepatology
- Published
- 2025-12-26
- DOI
- https://doi.org/10.4254/wjh.v17.i12.112835
- Primary Topic
- Liver physiology and pathology
- Type
- article
- Field-Weighted Citation Impact
- 0.00